1.
Clin Infect Dis
; 75(3): 515-518, 2022 08 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35020888
RESUMO
We analyzed samples obtained at baseline and 24 months in a mass azithromycin administration trial in Niger using quantitative polymerase chain reaction. In villages randomized to azithromycin, Shigella was the only pathogen reduced at 24 months (prevalence ratio, 0.36 [95% confidence interval: .17-.79]; difference in log quantity, -.42 [-.75 to -.10]).